387 related articles for article (PubMed ID: 22508377)
1. Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles.
Mendenhall A; Lesnik J; Mukherjee C; Antes T; Sengupta R
J Vis Exp; 2012 Apr; (62):e3171. PubMed ID: 22508377
[TBL] [Abstract][Full Text] [Related]
2. Production of lentiviral vectors for transducing cells from the central nervous system.
Li M; Husic N; Lin Y; Snider BJ
J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
[TBL] [Abstract][Full Text] [Related]
3. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
4. A new-generation stable inducible packaging cell line for lentiviral vectors.
Farson D; Witt R; McGuinness R; Dull T; Kelly M; Song J; Radeke R; Bukovsky A; Consiglio A; Naldini L
Hum Gene Ther; 2001 May; 12(8):981-97. PubMed ID: 11387062
[TBL] [Abstract][Full Text] [Related]
5. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
6. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles.
Mitta B; Rimann M; Fussenegger M
Metab Eng; 2005; 7(5-6):426-36. PubMed ID: 16102993
[TBL] [Abstract][Full Text] [Related]
7. Introducing a cleavable signal peptide enhances the packaging efficiency of lentiviral vectors pseudotyped with Japanese encephalitis virus envelope proteins.
Liu H; Wu R; Yuan L; Tian G; Huang X; Wen Y; Ma X; Huang Y; Yan Q; Zhao Q; Cao S; Wen X
Virus Res; 2017 Feb; 229():9-16. PubMed ID: 27993624
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
9. Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.
Chen Y; Miller WM; Aiyar A
Biotechnol Prog; 2005; 21(1):274-82. PubMed ID: 15903266
[TBL] [Abstract][Full Text] [Related]
10. Optimized protocol for high-titer lentivirus production and transduction of primary fibroblasts.
He X; He Q; Yu W; Huang J; Yang M; Chen W; Han W
J Basic Microbiol; 2021 May; 61(5):430-442. PubMed ID: 33683727
[TBL] [Abstract][Full Text] [Related]
11. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells.
Mochizuki H; Schwartz JP; Tanaka K; Brady RO; Reiser J
J Virol; 1998 Nov; 72(11):8873-83. PubMed ID: 9765432
[TBL] [Abstract][Full Text] [Related]
12. High-Titer Production of HIV-Based Lentiviral Vectors in Roller Bottles for Gene and Cell Therapy.
Olgun HB; Tasyurek HM; Sanlioglu AD; Sanlioglu S
Methods Mol Biol; 2019; 1879():323-345. PubMed ID: 29797007
[TBL] [Abstract][Full Text] [Related]
13. Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.
Sastry L; Johnson T; Hobson MJ; Smucker B; Cornetta K
Gene Ther; 2002 Sep; 9(17):1155-62. PubMed ID: 12170379
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo.
Zhao J; Pettigrew GJ; Thomas J; Vandenberg JI; Delriviere L; Bolton EM; Carmichael A; Martin JL; Marber MS; Lever AM
Basic Res Cardiol; 2002 Sep; 97(5):348-58. PubMed ID: 12200634
[TBL] [Abstract][Full Text] [Related]
15. Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes.
Pistello M; Vannucci L; Ravani A; Bonci F; Chiuppesi F; del Santo B; Freer G; Bendinelli M
Genet Vaccines Ther; 2007 Sep; 5():8. PubMed ID: 17880683
[TBL] [Abstract][Full Text] [Related]
16. Development of Lentiviral Vectors for Targeted Integration and Protein Delivery.
Schenkwein D; Ylä-Herttuala S
Methods Mol Biol; 2016; 1448():185-98. PubMed ID: 27317182
[TBL] [Abstract][Full Text] [Related]
17. In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins.
Kang Y; Stein CS; Heth JA; Sinn PL; Penisten AK; Staber PD; Ratliff KL; Shen H; Barker CK; Martins I; Sharkey CM; Sanders DA; McCray PB; Davidson BL
J Virol; 2002 Sep; 76(18):9378-88. PubMed ID: 12186920
[TBL] [Abstract][Full Text] [Related]
18. Comparison of wild-type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium.
Loewen N; Leske DA; Chen Y; Teo WL; Saenz DT; Peretz M; Holmes JM; Poeschla EM
J Gene Med; 2003 Dec; 5(12):1009-17. PubMed ID: 14661176
[TBL] [Abstract][Full Text] [Related]
19. A stable system for the high-titer production of multiply attenuated lentiviral vectors.
Klages N; Zufferey R; Trono D
Mol Ther; 2000 Aug; 2(2):170-6. PubMed ID: 10947945
[TBL] [Abstract][Full Text] [Related]
20. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]